Markets
NBP

I-Mab Appoints Dennis As CMO

June 06, 2024 — 07:25 am EDT

Written by RTTNews.com for RTTNews->

(RTTNews) - I-Mab (IMAB) announced Thursday that Phillip Dennis has been appointed Chief Medical Officer, effective June 17, 2024.

As CMO, Dennis will lead the global clinical development efforts of the Company and will be a member of I-Mab's Executive Leadership Team.

Dennis brings over two decades of experience in oncology drug development.

Prior to joining I-Mab, Dennis had served as Vice President of Lung Cancer Strategy and Global Project Head at Sanofi.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

NBP

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.